Neogen Corporation (NEOG) compared with its closest peers (MYGN, QDEL, CAI, LMRI, GH). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Myriad Genetics and QuidelOrtho share Neogen's sub-industry, diagnostics makers.
| Company | Market Cap | P/E |
|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $308.95M | -1.6 |
| QuidelOrtho Corporation (QDEL) | $955.26M | -1.8 |
| Caris Life Sciences, Inc. (CAI) | $7.16B | 68.1 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI) | $1.13B | 656.4 |
| Guardant Health, Inc. (GH) | $21.61B | -30.8 |
| Sotera Health Company (SHC) | $5.43B | 33.2 |
| Veracyte, Inc. (VCYT) | $3.56B | 31.1 |
| CareDx, Inc (CDNA) | $2.58B | 23.2 |
| RadNet, Inc. (RDNT) | $5.87B | -285.0 |
| Castle Biosciences, Inc. (CSTL) | $998.21M | -46.9 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.1 |
NEOG overview · NEOG earnings · NEOG financials · NEOG KPIs · NEOG documents · NEOG ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.